Bentsur Ron
Nuvectis Pharma, Inc. · Chairman & CEO
Bentsur Ron is listed in public filings as director, 10 percent owner, officer: Chairman & CEO. This Bentsur Ron insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Nuvectis Pharma, Inc. (NVCT). Investors use Bentsur Ron's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --3.7M shares | Grant / ExerciseJan 6, 2026 | Disclosure amount unavailable150k shares | -- | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $20M3.5M shares | BuyNov 5, 2025 | $28.6K5k shares | $5.72 | -- | |
| --3.5M shares | Grant / ExerciseJan 2, 2025 | Disclosure amount unavailable250k shares | -- | -- | |
| $15M3.3M shares | BuyDec 24, 2024 | $20.9K4.5k shares | $4.65 | -- | |
| $16M3.3M shares | BuyNov 15, 2024 | $98.4K20k shares | $4.92 | -- |